Glasgow

Glasgow ECMC

Glasgow ECMC aims to translate findings from laboratory programs and into clinical studies. In particular, the development of novel agents and using biological markers to optimise, target and individualise treatment. The Centre has an active early phase (phase I/II) clinical trial programme in both solid tumours and haematological malignancies.

Drug Development (early phase trials)
Gastrointestinal Cancers
Pancreatic Cancer
Chronic Myeloid Leukaemia
Neuro-Oncology / Radiation Therapy
Uro-Oncology
Ovarian Cancer

Drug Development (early phase trials)
Biological markers
Cellular Senescence
DNA damage response
Invasion and Metastasis
Autophagy
Epigenetics

Brain	Colorectal	Leukaemia	Pancreatic
Relevant to all cancer types

Goals

For further information on the goals and objectives of Glasgow ECMC go to:

More about Goals

Skills

Glasgow ECMC principal investigators and staff have a diverse range of skills and expertise.

More about Skills

Facilities

Glasgow ECMC has access to a range of research facilities that are utilised in studies.

More about Facilities